Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Invigorating kidney and promoting blood decoction (Bushen Huoxue Tang) is a Traditional Chinese Medicine (TCM) herbal formulation utilized primarily for the treatment of aplastic anemia. Developed and studied by Xiyuan Hospital of the China Academy of Traditional Chinese Sciences, the decoction is based on the therapeutic principles of tonifying the Kidney (associated with bone marrow and blood production in TCM) and activating blood circulation to resolve stasis. Clinical research, including cohort studies registered under ChiCTR-OOC-15006835, has focused on its efficacy in improving hematological parameters, enhancing the recovery of bone marrow function, and reducing the recurrence rate of aplastic anemia following standard treatments like immunosuppressive therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on invigorating kidney and promoting blood decoction.